Bellicum Pharma (BLCM) Misses Q2 EPS by 5c

Bellicum Pharma (NASDAQ: BLCM) reported Q2 EPS of ($0.60), $0.05 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Bellicum Pharma (BLCM) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• La-Z-Boy (LZB) Misses Q1 EPS by 6c, Misses on Revenue; Offers Weak Q2 Revenue Guidance
• Jack Henry (JKHY) Tops Q4 EPS by 13c